TLR7 and cutaneous melanoma: To confirm our in silico prediction, we performed immunohistochemistry (Extended Data Fig. 4a,b) and multiplex immunofluorescence for TLR7/8 in an independent cohort of patients with cutaneous melanoma (Fig. 4a,b, Extended Data Fig. 4c and Supplementary Figs. 1 and 2).